Lifecore Biomedical, Inc. (LFCR)
NASDAQ · Healthcare
Lifecore Biomedical, Inc. Income Statement 2010–2025
| May 2025 | May 2024 | May 2023 | May 2022 | May 2021 | May 2020 | May 2019 | May 2018 | May 2017 | May 2016 | May 2015 | May 2014 | May 2013 | May 2012 | May 2011 | May 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenue | 128.9M | 128.3M | 103.3M | 111.3M | 100.9M | 160.1M | 557.6M | 524.2M | 469.8M | 476.9M | 539.3M | 476.8M | 441.7M | 317.6M | 276.7M | 238.2M |
| Gross Profit | 40.3M | 41.9M | 28.0M | 39.1M | 38.9M | 39.4M | 81.0M | 78.3M | 79.2M | 66.8M | 65.4M | 62.6M | 62.8M | 52.1M | 46.7M | 33.8M |
| Profitability | ||||||||||||||||
| Operating Income | -17.2M | -8.8M | -21.8M | -11.8M | -8.8M | -25.9M | 5.5M | 13.6M | 14.7M | -20.6M | 18.5M | 20.2M | 24.9M | 14.6M | 8.0M | 8.0M |
| EBITDA | -9.2M | -890,000 | -8.6M | 6.3M | 11.0M | -7.0M | 20.7M | 26.0M | 25.3M | -11.2M | 25.6M | 27.3M | 32.2M | 20.2M | 13.3M | 11.3M |
| Net Income | -38.7M | 12.0M | -99.6M | -116.7M | -32.3M | -38.2M | 411,000 | 24.8M | 10.6M | -11.6M | 13.5M | 19.1M | 22.6M | 12.7M | 3.9M | 4.0M |
| Per Share Data | ||||||||||||||||
| EPS (diluted) | $-1.27 | $0.33 | $-3.32 | $-3.97 | $-1.10 | $-1.31 | $0.01 | $0.89 | $0.38 | $-0.43 | $0.50 | $0.71 | $0.85 | $0.49 | $0.15 | $0.15 |
| Shares Outstanding (dil.) | 35M | 37M | 30M | 29M | 29M | 29M | 29M | 28M | 28M | 27M | 27M | 27M | 0M | 26M | 27M | 0M |
Lifecore Biomedical, Inc. Income Statement — FAQ
Lifecore Biomedical, Inc. (LFCR) income statement over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LFCR's income statement history?
The chart and table above show Lifecore Biomedical, Inc.'s income statement by year and by quarter, including the growth rate.